» Articles » PMID: 31989000

Adipose-derived Stem Cells Improve Tendon Repair and Prevent Ectopic Ossification in Tendinopathy by Inhibiting Inflammation and Inducing Neovascularization in the Early Stage of Tendon Healing

Overview
Journal Regen Ther
Date 2020 Jan 29
PMID 31989000
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Achilles tendinopathy is characterized by scar formation or ectopic ossification, both of which result in pain and worsened physical function in athletes and older people. Although cell therapy using adipose-derived stem cells (ASCs) has been shown to be effective for tendinopathy, the underlying mechanisms by which ASCs result in tendon healing in vivo have not yet been fully clarified.

Methods: ASCs were obtained from the fat pads of EGFP transgenic mice by collagenase digestion. C57BL/6 mice were used in a collagenase-induced injury model. ASCs were transplanted into injury sites at 1 week after injury. Tendons were harvested at 9 days, 2 weeks, and 4 weeks after transplantation, and analyzed by histological examination and μCT scanning.

Results: Histological analysis and μCT scanning revealed greater recovery of collagen fibers and suppression of ectopic ossification in the ASC-treated group than in the control group at 2 and 4 weeks after injury. Immunohistochemical analysis identified transplanted ASCs in the tendon core close to peritenon and connective tissue at 2 days and 1 week after transplantation, but not at 3 weeks. Furthermore, while the expression levels of IL-1β, GLUT1, and CA9 were significantly reduced in the ASC group compared to the control group at 9 days after injury, those of VEGF and the number of CD31 positive vessels were significantly increased.

Conclusion: The efficacy of ASCs for tendon repair and the prevention of ectopic ossification in Achilles tendinopathy were demonstrated. Our data suggest that ASCs can modulate inflammation and induce neovascularization in the early stage of tendon injury.

Citing Articles

Treatment options for Achilles tendinopathy: a scoping review of preclinical studies.

Agyeman-Prempeh N, Maas H, Burchell G, Millar N, Moen M, Smit T PeerJ. 2025; 13():e18143.

PMID: 39807157 PMC: 11727660. DOI: 10.7717/peerj.18143.


Biological strategies in rotator cuff repair: a clinical application and molecular background.

Pawlak M, Walecka J, Lubiatowski P EFORT Open Rev. 2024; 9(12):1156-1169.

PMID: 39620574 PMC: 11619734. DOI: 10.1530/EOR-24-0012.


Recent developments in Achilles tendon risk-analyzing rupture factors for enhanced injury prevention and clinical guidance: Current implications of regenerative medicine.

Sankova M, Beeraka N, Oganesyan M, Rizaeva N, Sankov A, Shelestova O J Orthop Translat. 2024; 49:289-307.

PMID: 39559294 PMC: 11570240. DOI: 10.1016/j.jot.2024.08.024.


Advancements in Therapeutic Approaches for Degenerative Tendinopathy: Evaluating Efficacy and Challenges.

Morya V, Shahid H, Lang J, Kwak M, Park S, Noh K Int J Mol Sci. 2024; 25(21).

PMID: 39519397 PMC: 11545934. DOI: 10.3390/ijms252111846.


Classification of distinct tendinopathy subtypes for precision therapeutics.

Tang C, Wang Z, Xie Y, Fei Y, Luo J, Wang C Nat Commun. 2024; 15(1):9460.

PMID: 39487125 PMC: 11530571. DOI: 10.1038/s41467-024-53826-w.


References
1.
Ganestam A, Kallemose T, Troelsen A, Barfod K . Increasing incidence of acute Achilles tendon rupture and a noticeable decline in surgical treatment from 1994 to 2013. A nationwide registry study of 33,160 patients. Knee Surg Sports Traumatol Arthrosc. 2015; 24(12):3730-3737. DOI: 10.1007/s00167-015-3544-5. View

2.
Cook J, Feller J, Bonar S, Khan K . Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons. J Orthop Res. 2004; 22(2):334-8. DOI: 10.1016/j.orthres.2003.08.005. View

3.
Fenwick S, Hazleman B, Riley G . The vasculature and its role in the damaged and healing tendon. Arthritis Res. 2002; 4(4):252-60. PMC: 128932. DOI: 10.1186/ar416. View

4.
Okamoto N, Kushida T, Oe K, Umeda M, Ikehara S, Iida H . Treating Achilles tendon rupture in rats with bone-marrow-cell transplantation therapy. J Bone Joint Surg Am. 2010; 92(17):2776-84. DOI: 10.2106/JBJS.I.01325. View

5.
Zhang K, Asai S, Yu B, Enomoto-Iwamoto M . IL-1β irreversibly inhibits tenogenic differentiation and alters metabolism in injured tendon-derived progenitor cells in vitro. Biochem Biophys Res Commun. 2015; 463(4):667-72. PMC: 4496264. DOI: 10.1016/j.bbrc.2015.05.122. View